metabolomics research competition

NADMED launches $30,000 metabolomics competition

A Finnish biotechnology company has opened applications for a global scientific competition designed to advance understanding of cellular redox metabolism, offering successful applicants access to precision measurement technology and expert support valued at up to $30,000.

2 CS AED

New Chromsystems Product for Antiepileptic Drugs Testing

Chromsystems announces the launch and immediate availability of the MassTox® TDM Series A Parameter Set Antiepileptic Drugs XT2 in Serum/Plasma – All-in-One Method. The updated parameter set extends the MassTox® TDM portfolio, helping laboratories meet clinical needs and regulatory requirements in therapeutic drug monitoring.

DiaSys respons®c line

Trusted analytical solutions for reliable results

Discover the perfect solution for every laboratory size. Due to its compact design respons®240c is ideal for small labs that require an analyzer capable of a constant throughput of 240 tests/hour along with intuitively operated software. Advanced features like onboard hemolysis and a grated photometer with 12 wavelengths ensure precision and efficiency.

Scherm­afbeelding 2025 11 07 om 13.51.12

Chromsystems | Therapeutic Drug Monitoring by LC-MS/MS

MassTox® TDM Series A

Scherm­afbeelding 2025 11 07 om 13.41.55

SHIMADZU | CLAM-2040 goes live with RECIPE TDM platform

Shimadzu has been paving the way for automated LC-MS/MS (CLAM series) since 2015. Now it’s time for the next step into the future of the clinical laboratory. Discover the IVD kits from the RECIPE ClinMass® TDM platform now available to be used on Shimadzu’s automated IVDR class A solutions for LC-MS/MS! Benefit from LCMS 24/7 […]

Scherm­afbeelding 2025 11 10 om 12.46.14

DIASYS | ResponsA1C

One step HbA1c analyzer

Scherm­afbeelding 2025 11 10 om 12.39.37

WERFEN | HIT Testing in Minutes.

The on-demand solution that saves more than time.

Lonza TheraPEAK

Lonza extends TheraPEAK portfolio with AmpliCell cytokines and 293-GT medium for cell and gene therapy manufacturing

Lonza has launched two new products to strengthen its offering for cell and gene therapy developers: TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium. The additions address critical manufacturing requirements for immune cell expansion and adeno-associated virus (AAV) production, respectively.

Molcure AI drug discovery

Molcure partners with Boehringer Ingelheim to accelerate AI-driven antibody drug discovery

MOLCURE Inc. has announced a multiyear strategic research agreement with Boehringer Ingelheim to discover innovative antibody therapeutics for multiple targets using the Japanese company’s proprietary artificial intelligence platform technology. The collaboration will combine MOLCURE’s AI-driven platform with Boehringer Ingelheim’s expertise in biologics development, aiming to expand the scope and efficiency of antibody drug discovery beyond […]

bio rad Liquichek Opiate Control

Bio-Rad launches enhanced Liquichek Opiate Control

Bio-Rad Laboratories, a global provider of life science research and clinical diagnostics products, has improved its Liquichek quality control product portfolio with the launch of an enhanced version of its Liquichek Opiate Control.